SCHEMBL1463600

SCHEMBL1463600

C[CH]CCCC(C)CCCCCC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE2 Q9BYF1 1/20 0.48
PRKD3 O94806 1/20 0.42
PRKCG P05129 1/20 0.42
PRKCB P05771 1/20 0.42
PRKCA P17252 1/20 0.42
PRKCH P24723 1/20 0.42
PRKCI P41743 1/20 0.42
PRKCE Q02156 1/20 0.42
PRKCQ Q04759 1/20 0.42
PRKCZ Q05513 1/20 0.42
PRKCD Q05655 1/20 0.42
PRKD1 Q15139 1/20 0.42
OPRM1 P35372 1/20 0.41
ADH1B P00325 1/20 0.41
ADH1C P00326 1/20 0.41
ADH1A P07327 1/20 0.41
ADH4 P08319 1/20 0.41
ADH7 P40394 1/20 0.41
SPHK1 Q9NYA1 1/20 0.39
LMNA P02545 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28845556 1.00 ACE2 (0.48) ACE2PRKD3PRKCGPRKCBPRKCA
SCHEMBL28153758 1.00 ACE2 (0.48) ACE2PRKD3PRKCGPRKCBPRKCA
SCHEMBL28270184 1.00 ACE2 (0.48) ACE2PRKD3PRKCGPRKCBPRKCA
SCHEMBL28154757 1.00 ACE2 (0.48) ACE2PRKD3PRKCGPRKCBPRKCA
SCHEMBL10528855 0.98 ACE2 (0.45) ACE2PRKD3PRKCGPRKCBPRKCA
SCHEMBL28270183 0.95 ACE2 (0.48) ACE2PRKD3PRKCGPRKCBPRKCA
SCHEMBL28271636 0.95 ACE2 (0.48) ACE2PRKD3PRKCGPRKCBPRKCA
SCHEMBL1417505 0.95 ACE2 (0.48) ACE2PRKD3PRKCGPRKCBPRKCA
SCHEMBL28869035 0.95 ACE2 (0.48) ACE2PRKD3PRKCGPRKCBPRKCA
SCHEMBL28153799 0.95 ACE2 (0.48) ACE2PRKD3PRKCGPRKCBPRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106893581-B Organic electroluminescent compounds, organic electroluminescence device and its application 南京高光半导体材料有限公司 2019-11-05 CN disclosed
CN-106892914-B Organic electroluminescent compounds, organic electroluminescence device and its application 南京高光半导体材料有限公司 2019-02-01 CN disclosed
CN-108101922-A Organic electroluminescent compounds, organic electroluminescence device and its application 南京高光半导体材料有限公司 2018-06-01 CN disclosed
CN-106893581-A Organic electroluminescent compounds, organic electroluminescence device and its application 南京高光半导体材料有限公司 2017-06-27 CN disclosed
CN-106892914-A Organic electroluminescent compounds, organic electroluminescence device and its application 南京高光半导体材料有限公司 2017-06-27 CN disclosed
CN-106866498-A Organic compound, organic electroluminescence device and its application 南京高光半导体材料有限公司 2017-06-20 CN disclosed
EP-2382184-A2 MASS- AND PROPERTY-TUNED VARIABLE MASS LABELING REAGENTS AND ANALYTICAL METHODS FOR SIMULTANEOUS PEPTIDE SEQUENCING AND MULTIPLEXED PROTEIN QUANTIFICATION USING THEREOF Postech Academy-industry Foundation (KR) 2011-11-02 EP disclosed
US-20110071040-A1 MASS- AND PROPERTY-TUNED VARIABLE MASS LABELING REAGENTS AND ANALYTICAL METHODS FOR SIMULTANEOUS PEPTIDE SEQUENCING AND MULTIPLEXED PROTEIN QUANTIFICATION USING THEREOF POSTECH ACADEMY-INDUSTRY FOUNDATION (KR) 2011-03-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110071040-A1 MASS- AND PROPERTY-TUNED VARIABLE MASS LABELING REAGENTS AND ANALYTICAL METHODS FOR SIMULTANEOUS PEPTIDE SEQUENCING AND MULTIPLEXED PROTEIN QUANTIFICATION USING THEREOF SRMS, PTMS, QPCTL ACE2 3343/4885PRKD3 2695/4885PRKCG 1973/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.